CANADA LIFE ASSURANCE Co - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22
-55.1%
10,2760.0%0.00%
Q2 2023$49
+88.5%
10,276
+129.1%
0.00%
Q1 2023$26
-38.1%
4,485
+6.8%
0.00%
Q4 2022$42
-100.0%
4,199
+4.1%
0.00%
Q3 2022$91,000
-8.1%
4,032
+1.7%
0.00%
Q2 2022$99,000
-38.5%
3,965
+1.6%
0.00%
Q1 2022$161,000
-37.4%
3,902
-11.3%
0.00%
-100.0%
Q4 2021$257,000
-0.8%
4,399
+1.4%
0.00%0.0%
Q3 2021$259,000
-31.1%
4,3390.0%0.00%0.0%
Q2 2021$376,000
+5.6%
4,339
-0.3%
0.00%0.0%
Q1 2021$356,000
-8.5%
4,353
+1.3%
0.00%0.0%
Q4 2020$389,000
+126.2%
4,2970.0%0.00%
Q3 2020$172,000
+17.0%
4,2970.0%0.00%
Q2 2020$147,000
+53.1%
4,2970.0%0.00%
Q1 2020$96,000
+15.7%
4,2970.0%0.00%
Q4 2019$83,000
-48.8%
4,297
-46.3%
0.00%
Q2 2019$162,000
+15.7%
8,0030.0%0.00%
Q1 2019$140,000
+41.4%
8,0030.0%0.00%
Q4 2018$99,000
-23.8%
8,0030.0%0.00%
Q3 2018$130,000
+42.9%
8,0030.0%0.00%
Q2 2018$91,0008,0030.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$46,987,00060.92%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$278,604,00036.08%
Darwin Global Management, Ltd. 1,370,133$112,967,00022.12%
Redmile Group, LLC 12,957,222$1,068,323,00015.05%
Copernicus Capital Management, LLC 8,000$660,00010.66%
Casdin Capital, LLC 3,400,000$280,330,0008.35%
Grosvenor Holdings, L.L.C. 1,123,576$92,639,0006.81%
DAFNA Capital Management LLC 314,360$25,919,0006.15%
Ally Bridge Group (NY) LLC 270,000$22,262,0004.27%
Ghost Tree Capital, LLC 185,000$15,253,0003.58%
View complete list of FATE THERAPEUTICS INC shareholders